Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-01

Clinical Trial Update: In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigates the role of cholinergic and dopaminergic systems in the pathophysiology of apathy, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Apathy | Phase 3 | Status: UNKNOWN